Now in mid-stage clinical trials, Eli Lillys drug retatrutide (once-weekly injection) results in a weight loss of around 24% in obese adults
The collagen and GLP-1 connection that research reveals Here is where the science gets genuinely interesting
Though only a small percentage of people in these age groups are using GLP-1s in combination with surgery, there should be more done to ensure the best results for them down the road, the researchers say
To succeed, they must provide direct evidence that prescriptions or sales were diverted
which Pfizer claims conspired with Metsera and Novo Nordisk in furtherance of these anticompetitive activities. Pfizer claims the defendants are in violation of the Clayton Act, an act aimed at preventing anticompetitive practices and the Sherman Act, which outlaws monopolistic business practices
Our comprehensive medical weight loss program combines advanced medical expertise with personalized care to support your journey toward a healthier lifestyle